Andrea Matthews | Vice President of Corporate Affairs |
Jill Milne | Co-Founder and Chief Executive Officer |
Joanne Donovan | Chief Medical Officer and Senior Vice President, Clinical Development |
Andrew Nichols | Chief Scientific Officer |
Joel Beatty | Citi |
Liana Moussatos | Wedbush Securities |
Hartaj Singh | Oppenheimer & Co. Inc. |
Good day, ladies and gentlemen, and welcome to the Second Quarter 2018 Catabasis Pharmaceuticals Incorporated Earnings Conference Call. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this call may be recorded. I would now like to introduce your host for today's conference, Andrea Matthews, Vice President Corporate Affairs.